J&J Agrees to Buy Synthes for $21.3 Billion in Cash, Stock

J&J Agrees to Buy Synthes for $21.3 Billion in Cash, Stock

Daniel Acker/Bloomberg

The acquisition of Synthes Inc. would be the biggest in the 125-year history of Johnson & Johnson, which has had more than 50 drug and device recalls since the start of 2010.